Related Experiment Video
Updated: Oct 17, 2025
09:47
Generation of Retinal Organoids from Healthy and Retinal Disease-Specific Human-Induced Pluripotent Stem Cells
Published on: December 9, 2022
3.8K
Retinal Organoid Technology: Where Are We Now?
Zuming Zhang1, Zihui Xu1, Fa Yuan1
1State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 510060, China.
International Journal of Molecular Sciences
|October 13, 2021
Summary
Retinal organoids offer a new way to study eye development and disease, overcoming limitations in regenerating damaged adult retinal cells. This technology advances potential cell therapies for vision loss.
Area of Science:
- Ophthalmology
- Developmental Biology
- Regenerative Medicine
Background:
- Mammalian retinal cell regeneration is challenging, with limited clinical options for retinal damage.
- Retinal organoids provide a model for studying retinal development and disease pathogenesis.
- Current treatments for retinal damage face significant limitations.
Purpose of the Study:
- To review the historical development of retinal organoid technology.
- To categorize current methods for inducing retinal organoids.
- To discuss challenges and future directions for advanced retinal organoids and cell transplantation therapies.
Main Methods:
- Historical review of retinal organoid technology.
- Categorization of existing organoid induction protocols.
- Analysis of recent advancements in retinal cell and tissue transplantation.
Main Results:
- Retinal organoids facilitate the study of molecular mechanisms in retinal development.
- Organoids aid in exploring retinal disease pathogenesis and developing new treatments.
- The study compares single-cell suspension and retinal organoid sheet transplantation for cell therapies.
Conclusions:
- Retinal organoid technology is crucial for advancing retinal research and regenerative medicine.
- Future retinal organoids aim to overcome current obstacles for improved therapeutic potential.
- Cellular transplantation strategies, including organoid sheets, show promise for treating retinal diseases.
